IKA 2024: Specialty contact lenses with diseased and sick eyes

News
Video

Christine Sindt, OD, FAAO, Clinical Professor of Ophthalmology and Visual Sciences at the University of Iowa School of Medicine, talked about her session at the meeting focusing on higher order aberrations and the correction of complicated optics on scleral contact lenses.

Christine Sindt, OD, FAAO, Clinical Professor of Ophthalmology and Visual Sciences at the University of Iowa School of Medicine, talked about her session at the meeting focusing on higher order aberrations and the correction of complicated optics on scleral contact lenses.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

Christine Sindt, OD, FAAO:

Hi, I'm Dr. Christine Sindt and I am a professor of clinical ophthalmology at the University of Iowa. And my area of research is specialty contact lenses with diseased and sick eyes. And I am at the IKA meeting here in Bethesda, talking about higher order aberrations and the correction of complicated optics on scleral contact lenses. My session today, I'm really getting into who are the best candidates? Who should we avoid and what my research shows. What I have found is that patients that have scars or a lot of scatter, it seems intuitive, but they do have a decreased amount of appreciation when you put higher order aberrations on the lenses. But keratoconus patients in general do very well. And statistically I can correct about 65% of the aberrations on a keratoconic eye. I think this is important because it can lead for a better experience for the patient. It can lead to a better experience for the doctor and keep people out of surgery which is certainly the goal to keep our patients healthy.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
© 2025 MJH Life Sciences

All rights reserved.